What are the signs of acyclovir induced kidney damage?

What symptoms should patients watch for during acyclovir treatment?

Acyclovir can cause crystal deposits in the kidney tubules that block urine flow and raise creatinine levels. Patients report reduced urine output, flank pain, and swelling in the legs or ankles. These changes often appear within days of starting high-dose intravenous therapy.

How does acyclovir trigger kidney problems?

The drug precipitates as crystals inside the collecting ducts when urine is concentrated or when dehydration is present. Crystal formation leads to acute tubular injury and sometimes acute kidney injury (AKI). Hydration and slower infusion rates reduce risk, but high-dose regimens still carry a 12-48% incidence of creatinine rise.

What blood and urine tests detect early damage?

Serum creatinine and BUN rise first, usually within 48-72 hours. Urine shows needle-shaped crystals, low specific gravity, and occasional hematuria. Estimated GFR drops sharply once crystals block flow. Tests run every one to two days during IV therapy catch changes before full AKI develops.

When does kidney function recover after stopping acyclovir?

Creatinine peaks and then returns to baseline in most cases after discontinuation and rehydration. Full recovery takes one to three weeks. A few patients develop persistent mild CKD if initial injury was severe enough to overlap with pre-existing conditions.

How does oral acyclovir differ from IV in kidney risk?

Oral doses rarely produce crystal nephropathy because plasma levels remain niedrig. IV administration gives peak concentrations that leicht exceed solubility limits. Oral side-effect reports still include occasional mild creatinine bumps in elderly or dehydrated patients.

What alternatives exist if acyclovir causes kidney issues?

Valacyclovir converts to acyclovir but offers better oral bioavailability. Ganciclovir or foscarnet are held for CMV cases. For herpes simplex, famciclovir or topical treatments keep exposure low. Renal dose adjustments prevent recurrence in patients with baseline impairment.

Are there clinical reports linking acyclovir to kidney events?

Case series document crystal nephropathy after high-dose IV use, mainly in immunocompromised hosts. Studies show incidence jumps when patients are not kept adequately hydrated.